Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 1, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Retroperitoneal lymph node dissection (RPLND).

Oliver Zivanovic1, Joel Sheinfeld, Nadeem R Abu-Rustum

  • 1Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Gynecologic Oncology
|September 16, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can Novel Biomarkers Augment Traditional Surveillance Paradigms in Early-stage Testicular Germ Cell Tumors? A Case Study in Pre-clinical Relapse Detection Using a Combination Micro-RNA-371a-3p and 372-3p Assay.

Urology·2025
Same author

Validation of the Testicular Health Outcomes Report (THOR): a testicular cancer health-related quality of life instrument.

BJU international·2025
Same author

Baseline health-related quality-of-life metrics among patients with testicular germ cell tumours.

BJU international·2025
Same author

ASO Visual Abstract: Clinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma.

Annals of surgical oncology·2025
Same author

Pathologic and Oncologic Outcomes of Patients Undergoing Orchiectomy After Chemotherapy for Advanced Testicular Germ Cell Tumors.

European urology open science·2025
Same author

Clinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma.

Annals of surgical oncology·2025

Retroperitoneal lymph node dissection (RPLND) is crucial for staging gynecologic cancers and can improve survival in specific cases, particularly with ovarian immature teratoma. This article details the surgical anatomy and steps for performing RPLND.

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology
  • Cancer Metastasis

Background:

  • Pelvic and paraaortic lymph nodes are frequent sites of metastasis in gynecologic malignancies.
  • These lymph nodes can harbor chemoresistant tumor cells, impacting patient prognosis.
  • Accurate staging through lymph node evaluation aids in personalizing adjuvant therapy.

Purpose of the Study:

  • To outline the surgical anatomy relevant to retroperitoneal lymph node dissection (RPLND).
  • To describe the essential surgical steps for performing an extensive RPLND.
  • To underscore the importance of RPLND in the management of specific gynecologic malignancies.

Main Methods:

  • Detailed description of the surgical anatomy of the retroperitoneum.
  • Step-by-step procedural guide for retroperitoneal lymph node dissection.

More Related Videos

Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut
07:27

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut

Published on: December 30, 2025

Related Experiment Videos

Last Updated: Jul 1, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut
07:27

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut

Published on: December 30, 2025

  • Review of the role of RPLND in gynecologic oncology.

    • Main Results:

    • RPLND provides critical prognostic information for gynecologic malignancy patients.
    • RPLND has demonstrated survival benefits in chemorefractory ovarian immature teratoma.
    • RPLND is integral to post-chemotherapy debulking for nonseminomatous germ cell tumors.

    Conclusions:

    • Systematic lymphadenectomy, specifically RPLND, plays a vital role in staging and treatment of gynecologic cancers.
    • Proficiency in RPLND is an essential skill for gynecologic oncologists.
    • RPLND can be a therapeutic intervention, improving outcomes in select patient populations.